MIB1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.302000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.556600E-01
Normal-vs-Stage2
8.392000E-01
Normal-vs-Stage3
2.500200E-01
Normal-vs-Stage4
5.252300E-02
Stage1-vs-Stage2
6.233600E-01
Stage1-vs-Stage3
2.019600E-01
Stage1-vs-Stage4
7.901500E-03
Stage2-vs-Stage3
1.420770E-01
Stage2-vs-Stage4
5.740200E-03
Stage3-vs-Stage4
5.940200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.651200E-01
Normal-vs-AfricanAmerican
5.344400E-01
Normal-vs-Asian
8.860800E-01
Caucasian-vs-AfricanAmerican
3.522400E-01
Caucasian-vs-Asian
5.450200E-01
AfricanAmerican-vs-Asian
2.964400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.573800E-01
Normal-vs-Female
7.866400E-01
Male-vs-Female
7.910800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.508000E-01
Normal-vs-Age(41-60Yrs)
5.354600E-01
Normal-vs-Age(61-80Yrs)
9.341000E-01
Normal-vs-Age(81-100Yrs)
4.641600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.733000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.130800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.188160E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.013700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.566500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.343600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.052200E-01
Normal-vs-Daily Drinker
4.649000E-01
Normal-vs-Weekly Drinker
9.767200E-01
Normal-vs-Occasional Drinker
5.998800E-01
Normal-vs-Social Drinker
5.432600E-01
Non Drinker-vs-Daily Drinker
4.180000E-01
Non Drinker-vs-Weekly Drinker
4.909800E-01
Non Drinker-vs-Occasional Drinker
9.477700E-02
Non Drinker-vs-Social Drinker
9.492100E-02
Daily Drinker-vs-Weekly Drinker
2.287800E-01
Daily Drinker-vs-Occasional Drinker
3.858200E-02
Daily Drinker-vs-Social Drinker
4.681900E-02
Weekly Drinker-vs-Occasional Drinker
3.512800E-01
Weekly Drinker-vs-Social Drinker
2.639200E-01
Occasional Drinker-vs-Social Drinker
7.581400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.309350E-01
Normal-vs-Grade 2
2.440000E-02
Normal-vs-Grade 3
7.236200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.349600E-01
Grade 1-vs-Grade 3
3.259800E-01
Grade 1-vs-Grade 4
1.309350E-01
Grade 2-vs-Grade 3
2.519200E-01
Grade 2-vs-Grade 4
2.440000E-02
Grade 3-vs-Grade 4
7.236200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.791800E-01
Normal-vs-NonDiabetic
8.863400E-01
Diabetic-vs-NonDiabetic
6.548800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.643200E-01
Normal-vs-NoPancreatitis
8.525000E-01
Pancreatitis-vs-NoPancreatitis
6.155500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.383200E-01
Normal-vs-N1
8.074000E-01
N0-vs-N1
9.344400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.752400E-01
Normal-vs-TP53-NonMutant
7.797800E-01
TP53-Mutant-vs-TP53-NonMutant
2.111800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
